Campus alert status is green: For the latest UMMS campus alert status, news and resources, visit

Search Close Search

UMass Cancer Center

Our mission is to advance the cancer control continuum—from etiology through survivorship—in patients of all ages and with all types of cancer, through cutting-edge research, excellence in education, community-based outreach and the delivery of compassionate, patient-centered care.



Find Clinical Trials

The largest selection of advanced clinical trials in Central Massachusetts


Meet Our Clinicians

World-class patient care, offering the latest advances in personalized treatment approaches

Lab Image

Explore Cancer Research

Breakthroughs in research helping serve communities all around the world


Ways to Give

There are many ways to show your support for scientific research and patient care 


Research Programs

UMass Cancer Center is a powerhouse in cancer research. Our scientists and clinical researchers have been recruited from around the world and are leaders in their field who work to advance our understanding of cancer initiation, progression, treatment and prevention through groundbreaking basic, translational, clinical and population research.


Learn more


Help Us Make A Difference

Your help will make a enormous difference




Page Menu

UMass Cancer Center News

  • Research News

    Cantor lab rethinks how common chemotherapy drug used in breast and ovarian cancer works

    Research from the lab of Sharon Cantor, PhD, provides a new understanding of a PARP inhibitor, a chemotherapy drug commonly used against breast and ovarian cancer.

    Read more
  • Community News

    Katherine Fitzgerald and Nikolaus Grigorieff elected to National Academy of Sciences

    Two UMass Medical School professors have been elected to the National Academy of Sciences in recognition of their distinguished and continuing achievements in original research.

    Read more
  • Research News

    Roger Davis elected to American Academy of Arts & Sciences

    Roger J. Davis, PhD, FRS, has been elected a member of the American Academy of Arts & Sciences in recognition of his research on stress signaling pathways that are connected to a range of diseases, such as arthritis, cancer, stroke, heart disease and diabetes.

    Read more
  • Community News

    David McManus and Brian Lewis named to endowed chairs

    The University of Massachusetts Board of Trustees approved two “accomplished and visionary” University of Massachusetts faculty as endowed chairs at its April meeting.

    Read more
  • Research News

    UMMS establishes gene therapy collaborative research agreement with Pfizer

    UMass Medical School has entered into a three-year, collaborative research agreement with Pfizer to evaluate determinants that influence the manufacturing quality and yield of viral vectors used in gene therapy. The research at UMMS is being performed under the direction of Guangping Gao, PhD, and Dan Wang, PhD.

    Read more
  • Research News

    Erik Sontheimer co-leading efforts to develop gene editing toolkit by NIH Somatic Cell Genome Editing Consortium

    Six UMass Medical School scientists are among the members of the National Institutes of Health’s Somatic Cell Genome Editing Consortium to publish a paper in Nature outlining the program’s goals.

    Read more